Luc Y Dirix (David Gómez-Almaguer, Luc Dirix)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Venues

Breast cancer research and treatment

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Edgar Ulises Coronado-Alejandro, Martínez-Hernández Juan Pablo, Gómez-De León Andrés, Perla Rocío Colunga-Pedraza, José Carlos Jaime-Pérez, Olga Graciela Cantú-Rodríguez, Homero Gutiérrez-Aguirre César, Luc Y Dirix
Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia. European journal of haematology (2023)
Luc Y Dirix, Steffi Oeyen, Andy Buys, Vincent Liégois, Annemie Prové, Tom Van De Mooter, Steven Van Laere, Peter B Vermeulen
Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer. Breast cancer research and treatment 192 (3) (2022)
Luc Y Dirix, Andy Buys, Steffy Oeyen, Dieter Peeters, Vincent Liègeois, Annemie Prové, Dieter Rondas, Liesbet Vervoort, Véronique Mariën, Steven Van Laere, Peter Vermeulen
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer. Breast cancer research and treatment 193 (2) (2022)
Luc Y Dirix, Istvan Takacs, Guy Jerusalem, Petros Nikolinakos, Hendrik-Tobias Arkenau, Andres Forero-Torres, Ralph Boccia, Marc E Lippman, Robert Somer, Martin Smakal, Leisha A Emens, Borys Hrinczenko, William Edenfield, Jayne Gurtler, Anja von Heydebreck, Hans Juergen Grote, Kevin Chin, Erika P Hamilton
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study. Breast cancer research and treatment 167 (3) (2017)

Luc Y Dirix.css-eqlu8i{font-size:small;padding-left:4px;} (David Gómez-Almaguer, Luc Dirix)

Publication Activity (10 Years)

Top Topics

Top Venues

Luc Y Dirix (David Gómez-Almaguer, Luc Dirix)